Acrx stock zacks
Acelrx Pharmaceuticals Stock Quote: ACRX Stock News ... Oct 25, 2019 · ACRX, Acelrx Pharmaceuticals - Stock quote performance, technical chart analysis, Acelrx Pharmaceuticals (ACRX) - DEVELOPS THERAPIES FOR THE TREATMENT OF ACUTE POST-OPERATIVE PAIN AND CANCER BREAKTHROUGH PAIN. GROUP LEADERSHIP Zacks Equity Research 04/01/2020 02:18 AM ET. ACRX Price Target and Analyst Ratings (AcelRx Pharmaceuticals) Nov 01, 2019 · Their average twelve-month price target is $6.38, suggesting that the stock has a possible upside of 501.42%. The high price target for ACRX is $10.00 and the low price target for ACRX is $2.00. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus rating of "Buy." AcelRx Pharmaceuticals: 4Q Earnings Snapshot - ExpressNews.com Mar 16, 2020 · REDWOOD CITY, Calif. (AP) _ AcelRx Pharmaceuticals Inc. (ACRX) on Monday reported a loss of $14.4 million in its fourth quarter. The Redwood City, California-based company said it …
ACRX Stock | ACELRX PHARMACEUTICALS Stock Price Today ...
3 Jan 2020 AcelRx Pharmaceuticals (ACRX) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks Equity Research January 03, 2020. ACRX. 24 Feb 2020 During Q4 investors' call, AcelRx (ACRX) is likely to provide an update on the sales uptake of its Zacks Equity Research February 24, 2020. View live ACELRX PHARMACEUTICALS INC chart to track its stock's price action . Find market predictions, ACRX financials and market news. What are people saying about $ACRX? Stock Ticker for ACRX AcelRx Pharmaceuticals $ACRX Upgraded by Zacks Investment Research to “Buy” Get breaking news and analysis on AcelRx Pharmaceuticals, Inc. (ACRX) stock, price quote and chart, trading and investing tools at Zacks.com (Mar 27, 2020). See ACRX stock predictions by 3 financial experts and find out if their Acelrx stock forecast (ACRX) is more Zacks Equity Research Zacks Equity Research. In depth view into ACRX (AcelRx Pharmaceuticals) stock including the latest The Zacks Analyst Blog Highlights: AcelRx, BioCryst, Build-A-Bear, CACI and
AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy). 1 Simply Wall St. • 16 days ago
Jan 01, 2010 · AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and Acelrx Pharmaceuticals Stock Quote: ACRX Stock News ...
Pe Ratio (TTM) is a widely used stock evaluation measure. Find the latest Pe Ratio (TTM) for AcelRx Pharmaceuticals, Inc. (ACRX)
AcelRx Pharmaceuticals (ACRX) In Focus: Stock Moves 19.6% ... AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) was a big mover last session, as the company saw its shares rise nearly 20% on the day. The move came on solid volume too with far more shares changing ACRX / AcelRx Pharmaceuticals, Inc. - Institutional ...
AcelRx Pharmaceuticals (ACRX) Upgraded to Strong Buy: What ...
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) was a big mover last session, as the company saw its shares rise nearly 20% on the day. The move came on solid volume too with far more shares changing ACRX / AcelRx Pharmaceuticals, Inc. - Institutional ... Analysts Estimate AcelRx Pharmaceuticals (ACRX) to Report a Decline in Earnings: What to Look Out for. 07-25 zacks.com - 4 AcelRx Pharmaceuticals (ACRX - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2019. ACRX (AcelRx Pharmaceuticals) Stock Price and Chart - StockAP
ACRX: Get the latest AcelRx Pharmaceuticals stock price and detailed information including ACRX news, historical charts and realtime prices. ACRX | AcelRx Pharmaceuticals Inc. Profile | MarketWatch Nov 07, 2019 · AcelRx Pharmaceuticals Inc. company facts, information and stock details by MarketWatch. View acrx business summary and other industry information. AcelRx Pharmaceuticals, Inc. (ACRX) Stock Price, Quote ... Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock quote, history, news and other vital information to help you with your stock trading and investing. AcelRx Pharmaceuticals (NASDAQ:ACRX) Rating Increased to ... 10 days ago · AcelRx Pharmaceuticals (NASDAQ:ACRX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Friday, Zacks.com reports. The firm currently has a $1.50 target price on the specialty pharmaceutical company’s stock.